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Editorial Comment 
Acquired Immune Deficiency 
Syndrome: The Heart of 
the Matter* 
STEPHEN M. FACTOR, MD, FACC 
Btmx, New York 
At the beginning of this century, Sir William Osler is alleged 
to have expressed the opinion that to know syphilis is to 
know all of medicine because of the multisystem involve- 
ment and variable manifestations of the disease. In that era. 
before sophisticated diagnostic techniques and effective 
treatment, recognition of the cardiovascular complications 
of syphilis was obvious with palpation of the pulse and 
auscultation of the heart sounds. Today we are faced with a 
new public health scourge: acquired immune deficiency 
syndrome (AIDS). Almost at the end of the century, we can 
now say that in many respects to know AIDS is to know 
medicine. The generalized effects of the human immunode- 
ficiency virus (HIV) on organ function and susceptibility of 
tissues to infection make AIDS the protean disease of our 
era. Yet, despite ample documentation of the pulmonary, 
gastrointestinal, cerebral, integumentary and hematologic 
complications of AIDS, and despite our technologically 
superior diagnostic tools. relatively little is known about the 
clinicd cardiovascular manifestations of HIV infection. The 
paper by Himelman and coworkers (1) in the present issue of 
the Journal goes far to redress this imbalance. 
Present study. The authors present their findings of echo- 
cardiographic abnormalities in a cohort of hospitalized and 
outpatient individuals with overt AIDS or HIV infection, or 
both. The significant observation is the relatively high prev- 
alence of dilated cardiomyopathy in the hospitalized group 
(I 1% overall and 25% of the hospitalized patients), including 
four patients in whom the diagnosis was unsuspected. Al- 
though it can be assumed that the in-patients were sicker and 
may have had their disease for a longer period of time than 
the ambulatory group, there does not seem to be a direct 
correlation in this study between the types of opportunistic 
infections, malignancies and treatment regimens used in the 
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affected patients and the development of dilated cardiomy- 
opathy. In addition. despite the small numbers, there is a 
suggestion that the diagnosis of dilated cardiomyopathy on 
echocardiography has ominous implications for prognosis, 
with 50% of the patients with cardiomyopathy dead within 6 
months. Thus, if one can generalize from these results, 
hospitalized patients (particularly those with dyspnea) can- 
not be assumed necessarily to have a pulmonary cause for 
their symptoms, but may have primary AIDS-related cardiac 
dysfunction. Several questions can be posed based on these 
findings: 
Can the results be generalized? As indicated previously, 
there are very few clinical studies with which to compare the 
observations of Himelman et al. (l), certainly none as 
carefully performed or as well controlled. Fink et al. (2) 
reported echocardiographic abnormalities in 1.5 AIDS pa- 
tients and noted 20% with a hypokinetic left ventricle. 
Raffanti et al. (3) described electrocardiographic, echocar- 
diographic and ventriculographic abnormalities in 9 of 12 
AIDS patients, with 5 showing evidence of significant ven- 
tricular dysfunction. Recently, in two preliminary reports 
(4,s). the prevalence of echocardiographic features consis- 
tent with cardiomyopathy in AIDS patients was approxi- 
mately 30% to 40%. Thus, it would appear that as more 
studies are reported, there is increasing evidence of signifi- 
cant cardiac manifestations of HIV infection, including 
cardiomyopathy. 
Caution should be taken, however, in assuming that all 
HIV-infected patients are equivalent regardless of risk fac- 
tors. Most of the large studies of cardiac disease in AIDS 
(including the Himelman study [I]) published to date, 
whether clinical or pathologic (6-Q appear to have dealt 
primarily with homosexual patients with AIDS. Whether the 
findings in these studies are referable to all patients with HIV 
infection is still unknown. However, in a recently completed 
study from my institution (9), we observed that the preva- 
lence of idiopathic myocarditis and dilated cardiomyopathy 
was significantly higher in a group of patients with intrave- 
nous drug abuse as their primary risk factor than the 
prevalence in homosexual patients. Distinguishing among 
risk factors as a cause of variable disease prevalence has not 
been done with any frequency. It remains to be determined 
if risk factors alone can skew results from different groups 
with AIDS. 
What is the relation of these findings to tissue studies? 
Pathologic studies of AIDS patients (6-8) have reported 
variable frequencies of idiopathic myocarditis and cardiomy- 
opathy as well as identifiable infectious agents in myocardial 
tissue. It is clear from these reports that there are individuals 
with characteristic dilated cardiomyopathy in whom no 
specific cause other than HIV infection can be found. In this 
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regard there are now two reports of the AIDS virus being 
present in cardiac tissue, identified either by culture (101 or 
Southern blots (11). Whether the virus actually causes 
cardiomyopathy is yet undetermined. It is unfortunate that 
the study by Himelman et al. (1) did not include an analysis 
of endomyocardial biopsy tissue to correlate their echocar- 
diographic findings with morphologic findings and tech- 
niques to identify viral genomes. 
What are the implications of these findings? The increas- 
ing evidence of HIV-related cardiac disease supported by 
autopsy studies and now echocardiography strongly sug- 
gests that a greater effort should be made to elucidate the 
pathogenesis of AIDS cardiomyopathy and myocarditis. 
Although one could argue that there is little that can be 
offered to the victims of AIDS, the nihilistic approach is 
self-defeating. Just as the studies of cardiovascular syphilis 
led to advances in immunology, pharmacology and patho- 
physiology, from studies of patients with AIDS-related heart 
disease we may learn more about myocardial virology and 
immunology with implications for other non-HIV causes of 
myocarditis and cardiomyopathy. Finally, as is apparent in 
the study of Himelman and colleagues (I), the appropriate 
palliation of AIDS symptoms, particularly dyspnea not ex- 
plainable by pulmonary complications, is dependent on the 
recognition of a cardiac cause. Accordingly, it seems appro- 
priate to agree with the final recommendations of the authors 
that hospitalized AIDS patients should be considered for 
evaluation by echocardiography. 
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